A multi-national study examined the response sustainability to calcineurin inhibitors and long-term kidney survivals in children with genetic podocytopathies
Kidney International · 2026
DOI: 10.1016/j.kint.2026.06.030 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Kidney International, 2026. Verfasst von Georgia Malakasioti und 42 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Nephrology, P. & A. Kyriakou Children's Hospital, Athens, Greece. Hauptthemen laut MEDLINE: Calcineurin Inhibitors, Proteinuria, Podocytes. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
INTRODUCTION: While calcineurin inhibitors (CNIs) reduce proteinuria in a subgroup of children with genetic podocytopathies, previous reports suggest that the response is short-lived and of no benefit to long-term outcomes. Here, we assess CNI response sustainability and the association between different patterns of response preservation and kidney survival. METHODS: We performed a retrospective cohort study of patients aged 0-18 years with genetic podocytopathies treated with CNIs for at least three months from 34 pediatric nephrology centers worldwide. Response status was defined in accordance with International Pediatric Nephrology Association Clinical Practice Recommendations. RESULTS: We analyzed 136 patients with genetic podocytopathies over a median follow-up period of 42.1 months (between CNI initiation and last follow-up or commencement of kidney replacement therapy, whichever occurred first). At least partial response was attained in 28% and 22% of patients at six months post-CNI initiation and last follow-up, respectively. Compared to no response group, patients with at least partial response at six months had significantly lower urine protein-to-creatinine ratios across various time points post-CNIs. 71%, 11% and 18% exhibited no response, non-sustained and sustained response, respectively, throughout the observation period. Both sustained and non-sustained responses were significantly associated with superior kidney survival compared to no response. Importantly, no patients with sustained response developed kidney failure over a follow-up period of 42 (interquartile range 19-62) months. Patients with non-sustained response had a 92% lower risk of kidney failure compared to non-responders. CONCLUSIONS: A subset of children with genetic podocytopathies experienced a sustained response to CNIs, and none developed kidney failure. Children with non-sustained response still demonstrated superior kidney survival compared to non-responders. Our findings may support a trial of CNIs in genetic podocytopathies, and continuing therapy among those showing clinical response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Nephrology, P. & A. Kyriakou Children's Hospital, Athens, Greece.
- Wessex Clinical Genetics Service, University Hospital Southampton, Southampton, United Kingdom.
- Department of Pediatrics, The Chinese University of Hong Kong, Shatin, Hong Kong; Translational Medicine, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.
- Department of Pediatrics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong.
- National Medical Research Center of Children's Health, Moscow, Russia.
- Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan.
Zitieren
APA
Malakasioti, G., Iancu, D., Au, C. T., Zhou, D., Milovanova, A., Tsygin, A., Horinouchi, T., Nagano, C., Nozu, K., Kamei, K., Fujinaga, S., Iijima, K., Kang, H. G., Lim, S. H., Sinha, R., Basu, B., Morello, W., Montini, G., Waters, A., …, & CNI in Monogenic SRNS Study Investigators (2026). A multi-national study examined the response sustainability to calcineurin inhibitors and long-term kidney survivals in children with genetic podocytopathies. Kidney International. https://doi.org/10.1016/j.kint.2026.06.030
Vancouver
Malakasioti G, Iancu D, Au CT, Zhou D, Milovanova A, Tsygin A, et al. A multi-national study examined the response sustainability to calcineurin inhibitors and long-term kidney survivals in children with genetic podocytopathies. Kidney International. 2026. doi:10.1016/j.kint.2026.06.030
BibTeX
@article{Malakasioti2026,
author = {Malakasioti, Georgia and Iancu, Daniela and Au, Chun Ting and Zhou, Dongyang and Milovanova, Anastasiia and Tsygin, Alexey and Horinouchi, Tomoko and Nagano, China and Nozu, Kandai and Kamei, Koichi and Fujinaga, Shuichiro and Iijima, Kazumoto and Kang, Hee Gyung and Lim, Seon Hee and Sinha, Rajiv and Basu, Biswanath and Morello, William and Montini, Giovanni and Waters, Aoife and Boyer, Olivia and Yıldırım, Zeynep Yürük and Yel, Sibel and Dursun, İsmail and McCarthy, Hugh J and Massella, Laura and Vivarelli, Marina and Prikhodina, Larisa and Besouw, Martine T P and Huang, Wenyan and Kemper, Markus J and Loos, Sebastian and Prestidge, Chanel and Zlatanova, Galia and Ehren, Rasmus and Weber, Lutz T and Chehade, Hassib and Hooman, Nakysa and Tkaczyk, Marcin and Stańczyk, Małgorzata and Trachtman, Howard and Chan, Eugene Yu-Hin and Tullus, Kjell and CNI in Monogenic SRNS Study Investigators, CNI in Monogenic SRNS Study Investigators},
title = {A multi-national study examined the response sustainability to calcineurin inhibitors and long-term kidney survivals in children with genetic podocytopathies},
journal = {Kidney International},
year = {2026},
doi = {10.1016/j.kint.2026.06.030}
}
EUVIMED